Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia LIPITOR is an HMG-CoA reductase inhibitor (statin) indicated US FDA label
Kidney dosing: Atorvastatin (single-agent)Show full dosing details
- eGFR ≥60
- No adjustment (label).
- eGFR 30–59
- No adjustment (label). Monitor for myopathy. KDIGO: atorvastatin 20 mg/day is the studied dose in CKD G3a–G5; higher doses not proven safe in CKD.
- eGFR 15–29
- No adjustment (label). Monitor for myopathy. KDIGO: atorvastatin 20 mg/day is the studied dose in CKD G3a–G5; higher doses not proven safe in CKD.
- eGFR <15 (not on dialysis)
- No adjustment (label). Monitor for myopathy. KDIGO: atorvastatin 20 mg/day is the studied dose in CKD G3a–G5; higher doses not proven safe in CKD.
- Hemodialysis (intermittent)
- No dose adjustment (not dialyzed; label). KDIGO: do not start a statin in most patients already on dialysis; continue if already taking one at dialysis initiation.
- Peritoneal dialysis
- No label adjustment; no PD data.
- CRRT
- No data in label.
- Dialyzable? Not expected to be significantly removed by hemodialysis (label).
- Monitoring Muscle symptoms (myopathy, rhabdomyolysis); renal impairment is a risk factor (label).
From the Atorvastatin monograph (renalcarematters.com, reviewed).
Use: to reduce triglyceride (TG) levels in adults with severe hypertriglyceridemia (TG greater than or equal to 500 mg/dL). to reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia… US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 10 mg/160 mg, 20 mg/160 mg, 160 mg/10 mg
Registered products in the Philippines
7 products registered with the Food and Drug Administration (FDA) Philippines list Atorvastatin + Fenofibrate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products7
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AtorfibrateAtorvastatin (as calcium) + Fenofibrate | 10mg/160mg Film-coated TabletAlu / Alu Blister pack x 10's (Box of 30's) | RxVAT-exempt | Samson Laboratories Pvt. Ltd.India | A. Pendragon International Distribution OpcImporter: Khriz Pharma Trading Inc. | DRP-13177-01 | Dec 14, 2027 | |
Atorsam-FAtorvastatin (As Calcium) + Fenofibrate | 10mg/160mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Samson Laboratories Pvt. Ltd.India | Khriz Pharma Trading Inc. | DRP-13177 | Dec 14, 2027 | |
FenostatAtorvastatin (as calcium) + Fenofibrate | 10 mg/160 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Ajanta Pharma LimitedIndia | Ajanta Pharma Philippines, Inc. | DR-XY48064 | Feb 9, 2031 | |
FenostatAtorvastatin (as calcium) + Fenofibrate | 10mg/160mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's | RxVAT-exempt | Ajanta Pharma Ltd.India | Ajanta Pharma Philippines, Inc. | DR-XY39060 | Feb 21, 2029 | |
FenostatAtorvastatin (as calcium) + Fenofibrate | 20 mg/160 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Ajanta Pharma Ltd.India | Ajanta Pharma Philippines, Inc. | DR-XY44324 | Feb 9, 2031 | |
FenostatAtorvastatin (as calcium) + Fenofibrate | 20 mg/160 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Ajanta Pharma LimitedIndia | Ajanta Pharma Philippines, Inc. | DR-XY48063 | Feb 11, 2031 | |
FibrovasFenofibrate + Atorvastatin (as calcium) | 160 mg/10 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 30's) | RxVAT-exempt | Micro Labs LimitedIndia | Brown & Burk Philippines Inc | DR-XY46755 | Oct 24, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .
